Hannah Joseph Hospital Limited IPO Opens on January 22, 2026

Left to right: Dr. Sunil Kumar Manocha, CapitalSquare Advisors; Dr. Mosesjoseph Arunkumar; Mr. Daniel Dayanand Fenn; and Mr. Pandiarajan Thangaraj, Hannah Joseph Hospital Limited.

Mumbai (Maharashtra) [India], January 20: Hannah Joseph Hospital Limited (Hannah Joseph, The Company) a multi-specialty tertiary care hospital in Madurai with focus on Neurosciences and Trauma, proposes to open its Initial Public Offering on January 22, 2026, aiming to raise ₹ ₹ 42.00 Crore (At Upper Price Band) by fresh issue of 60,00,000 equity shares, to be listed on the BSE SME platform.

The issue size is 60,00,000 equity shares at a face value of ₹10 each, with a price band of ₹67-70 per share.

Equity Share Allocation

• Qualified Institutional Buyer – Not more than 28,46,000 Equity Shares

• Non-Institutional Investors – Not less than 8,58,000 Equity Shares

• Individual Investors – Not less than 19,96,000 Equity Shares

• Market Maker – 3,00,000 Equity Shares

The net proceeds from the IPO will be utilized for Funding of capital expenditure for establishing Radiation Oncology Centre and General Corporate Purposes. The anchor portion will open on Wednesday, January 21, 2026 and the issue will open on Thursday, January 22, 2026 and will close on Tuesday, January 27, 2026.

The Book Running Lead Manager to the Issue Capital SquareAdvisors Private Limited, The Registrar to the Issue isBigshare Services Private Limited.

Dr. Mosesjoseph Arunkumar, Chairman and Managing Director of Hannah Joseph Hospital Limited expressed, “Since its inception, remained committed to delivering advanced, ethical, and patient-centric healthcare services. Our evolution from a single-specialty focus to a multi-specialty tertiary care hospital reflects our continuous investments in clinical excellence, technology, and skilled medical professionals. Being a regional referral center for complex neurological, neurosurgical, cardiac, and trauma care, we have consistently strengthened our infrastructure and clinical capabilities to meet the growing healthcare needs of South Tamil Nadu.

The proposed IPO is expected to support the Company’s planned capacity and service expansion initiatives, enabling it to strengthen its clinical offerings and deliver more integrated, end-to-end care. These initiatives are aimed at enhancing patient convenience and treatment outcomes while broadening the Company’s ability to serve complex medical needs under a single platform. The expansion is also expected to drive incremental inpatient and outpatient volumes and support sustainable growth in revenues over the medium to long term.”

Mr. Sunil Kumar Manocha, Founder & Director of Capital Square Advisors Private Limited said, “Hannah Joseph Hospital operates a tertiary care facility in its core market with a focused presence across neurosciences, cardiology, trauma, and critical care. Supported by accredited operations and participation in government insurance schemes, the hospital is positioned to deploy incremental capital towards capacity enhancement and service integration initiatives.

These initiatives are expected to expand clinical offerings, improve patient throughput and case mix, and support growth in inpatient and outpatient revenues.”

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Related Posts

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew…

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 &…

You Missed

Parul University Moves up in QS World University Rankings: Asia 2027 with a Rank in the 791-800; and Secures 239th Position in Southern Asia

Parul University Moves up in QS World University Rankings: Asia 2027 with a Rank in the 791-800; and Secures 239th Position in Southern Asia

Chandan Sanwal Marks 10 Years of The Chandigarh Bytes, Crossing 1 Billion Views

Chandan Sanwal Marks 10 Years of The Chandigarh Bytes, Crossing 1 Billion Views

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Avi Basu of Wingsure: Turning Farm-Level Intelligence into Better Decisions Across Agriculture

Avi Basu of Wingsure: Turning Farm-Level Intelligence into Better Decisions Across Agriculture